|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
107,850,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
124,527 |
289,711 |
366,947 |
559,547 |
| Total Sell Value |
$8,826,266 |
$19,152,247 |
$23,008,468 |
$28,095,276 |
| Total People Sold |
5 |
6 |
6 |
8 |
| Total Sell Transactions |
16 |
36 |
45 |
80 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Coulter James G |
Former 10% Owner |
– – – |
2020-12-15 |
4 |
S |
$32.46 |
$2,664,691 |
I/I |
(81,979) |
5,074,574 |
|
- |
|
| Newell William J |
Director |
– • – |
2020-12-09 |
4 |
A |
$1.29 |
$28,674 |
D/D |
22,228 |
66,684 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-10-08 |
4 |
S |
$50.69 |
$8,498,065 |
I/I |
(167,661) |
5,001,593 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-10-07 |
4 |
S |
$50.95 |
$5,023,527 |
I/I |
(98,597) |
5,169,254 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-10-01 |
4 |
S |
$48.64 |
$776,705 |
I/I |
(15,967) |
0 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-09-30 |
4 |
S |
$50.27 |
$6,265,871 |
I/I |
(124,656) |
5,283,818 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-09-29 |
4 |
S |
$52.08 |
$4,202,987 |
I/I |
(80,707) |
5,408,474 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-06-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,489,181 |
|
- |
|
| Coulter James G |
10% Owner |
– – • |
2020-06-16 |
4 |
B |
$16.00 |
$15,000,000 |
I/I |
937,500 |
5,156,553 |
1.5 |
- |
|
| Coulter James G |
10% Owner |
– – • |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
4,219,053 |
4,219,053 |
|
- |
|
| Emster Kurt Von |
Director |
– • – |
2020-06-16 |
4 |
B |
$16.00 |
$200,000 |
I/I |
12,500 |
4,168,718 |
2.1 |
- |
|
| Emster Kurt Von |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
4,156,218 |
4,156,218 |
|
- |
|
| Heron Patrick J |
Director |
– • – |
2020-06-16 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
2,309,554 |
2.1 |
- |
|
| Heron Patrick J |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,059,554 |
2,059,554 |
|
- |
|
| Hopfner Robert Lorne |
Director |
– • – |
2020-06-16 |
4 |
B |
$16.00 |
$1,488,000 |
I/I |
93,000 |
2,222,967 |
2.1 |
- |
|
| Hopfner Robert Lorne |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,129,967 |
2,129,967 |
|
- |
|
| Sauer Paul |
SVP Process Dev, Manufacturing |
• – – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
76,615 |
|
- |
|
| Pickering Grant |
President & CEOOfficer |
• • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
355,660 |
|
- |
|
| Pickering Grant |
President & CEOOfficer |
• • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
571,629 |
|
- |
|
| Wassil Jim |
Chief Operating OfficerOfficer |
• – – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,819 |
|
- |
|
| Newell William J |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
44,456 |
|
- |
|
| Fairman Jeff |
VP, ResearchOfficer |
• – – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
391,227 |
|
- |
|
| Hirth Peter |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,113 |
|
- |
|
| Slaoui Moncef |
Director |
– • – |
2020-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,566 |
|
- |
|
349 Records found
|
|
Page 14 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
